Who invested in Integrated BioTherapeutics?
Integrated BioTherapeutics's investors include National Institutes of Health and National Institute of Allergy and Infectious Diseases.
United States · Venture startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$1.0Mraised across 1 round since 2023, from 1 source
Source recordedSEC filing: $1.0M sold, first sale May 2023
Integrated BioTherapeutics's investors include National Institutes of Health and National Institute of Allergy and Infectious Diseases.
Integrated BioTherapeutics has raised $1.0M across 1 round since 2023.
Integrated BioTherapeutics's most recent round was a Venture of $1.0M in May 2023.
Its most recent round, $1.0M in May 2023, is also its largest on record.
Integrated BioTherapeutics's first round on record, in May 2023, was backed by National Institutes of Health and National Institute of Allergy and Infectious Diseases.
Integrated BioTherapeutics's latest named round is a Venture, in May 2023.
Integrated BioTherapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.